 | • レポートコード：C-GIR20G1795 • 出版社/出版日：GlobalInfoResearch / 2019年12月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「組換えヒトインスリンの世界市場2019年」は、グローバルにおける組換えヒトインスリン市場を展望するレポートです。組換えヒトインスリンのグローバル市場概観、メーカー動向、メーカー別シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどを掲載しています。 ・組換えヒトインスリンの市場概観 ・組換えヒトインスリンの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・組換えヒトインスリンの企業別販売動向、市場シェア、市場集中度、競争動向 ・組換えヒトインスリンの世界市場規模 ・組換えヒトインスリンの北米市場分析（アメリカ、カナダ、メキシコ等） ・組換えヒトインスリンのアメリカ市場規模推移 ・組換えヒトインスリンのカナダ市場規模推移 ・組換えヒトインスリンのメキシコ市場規模推移 ・組換えヒトインスリンのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・組換えヒトインスリンのドイツ市場規模推移 ・組換えヒトインスリンのイギリス市場規模推移 ・組換えヒトインスリンのロシア市場規模推移 ・組換えヒトインスリンのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・組換えヒトインスリンの日本市場規模推移 ・組換えヒトインスリンの中国市場規模推移 ・組換えヒトインスリンの韓国市場規模推移 ・組換えヒトインスリンのインド市場規模推移 ・組換えヒトインスリンの東南アジア市場規模推移 ・組換えヒトインスリンの南米市場分析（ブラジル、アルゼンチン等） ・組換えヒトインスリンの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・組換えヒトインスリンの種類別分析/販売量、売上、市場シェア（） ・組換えヒトインスリンの用途別分析/市場規模（1型糖尿病、2型糖尿病） ・組換えヒトインスリンの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・組換えヒトインスリンの販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The worldwide market for Recombinant Human Insulin is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Recombinant Human Insulin in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Dongbro Pharmaceuticri
Novo Nordisk
Wockhardt
Akron Biotech
Dance Biopharm
United Laboratories
Gan & Lee
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Market Segment by Applications, can be divided into
Type 1 Diabetes Mellitus
Type 2 Diabetes Mellitus
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Recombinant Human Insulin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Recombinant Human Insulin, with price, sales, revenue and global market share of Recombinant Human Insulin in 2017 and 2018.
Chapter 3, the Recombinant Human Insulin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Recombinant Human Insulin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Recombinant Human Insulin market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Recombinant Human Insulin sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Recombinant Human Insulin Introduction
1.2 Market Analysis by Type
1.3 Market Analysis by Applications
1.3.1 Type 1 Diabetes Mellitus
1.3.2 Type 2 Diabetes Mellitus
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Dongbro Pharmaceuticri
2.1.1 Business Overview
2.1.2 Recombinant Human Insulin Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Dongbro Pharmaceuticri Recombinant Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Novo Nordisk
2.2.1 Business Overview
2.2.2 Recombinant Human Insulin Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novo Nordisk Recombinant Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Wockhardt
2.3.1 Business Overview
2.3.2 Recombinant Human Insulin Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Wockhardt Recombinant Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Akron Biotech
2.4.1 Business Overview
2.4.2 Recombinant Human Insulin Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Akron Biotech Recombinant Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Dance Biopharm
2.5.1 Business Overview
2.5.2 Recombinant Human Insulin Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Dance Biopharm Recombinant Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 United Laboratories
2.6.1 Business Overview
2.6.2 Recombinant Human Insulin Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 United Laboratories Recombinant Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Gan & Lee
2.7.1 Business Overview
2.7.2 Recombinant Human Insulin Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Gan & Lee Recombinant Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Recombinant Human Insulin Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Recombinant Human Insulin Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Recombinant Human Insulin Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Recombinant Human Insulin Manufacturer Market Share in 2018
3.3.2 Top 6 Recombinant Human Insulin Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Recombinant Human Insulin Market Analysis by Regions
4.1 Global Recombinant Human Insulin Sales, Revenue and Market Share by Regions
4.1.1 Global Recombinant Human Insulin Sales and Market Share by Regions (2014-2019)
4.1.2 Global Recombinant Human Insulin Revenue and Market Share by Regions (2014-2019)
4.2 North America Recombinant Human Insulin Sales and Growth Rate (2014-2019)
4.3 Europe Recombinant Human Insulin Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Recombinant Human Insulin Sales and Growth Rate (2014-2019)
4.5 South America Recombinant Human Insulin Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Recombinant Human Insulin Sales and Growth Rate (2014-2019)
5 North America Recombinant Human Insulin by Country
5.1 North America Recombinant Human Insulin Sales, Revenue and Market Share by Country
5.1.1 North America Recombinant Human Insulin Sales and Market Share by Country (2014-2019)
5.1.2 North America Recombinant Human Insulin Revenue and Market Share by Country (2014-2019)
5.2 United States Recombinant Human Insulin Sales and Growth Rate (2014-2019)
5.3 Canada Recombinant Human Insulin Sales and Growth Rate (2014-2019)
5.4 Mexico Recombinant Human Insulin Sales and Growth Rate (2014-2019)
6 Europe Recombinant Human Insulin by Country
6.1 Europe Recombinant Human Insulin Sales, Revenue and Market Share by Country
6.1.1 Europe Recombinant Human Insulin Sales and Market Share by Country (2014-2019)
6.1.2 Europe Recombinant Human Insulin Revenue and Market Share by Country (2014-2019)
6.2 Germany Recombinant Human Insulin Sales and Growth Rate (2014-2019)
6.3 UK Recombinant Human Insulin Sales and Growth Rate (2014-2019)
6.4 France Recombinant Human Insulin Sales and Growth Rate (2014-2019)
6.5 Russia Recombinant Human Insulin Sales and Growth Rate (2014-2019)
6.6 Italy Recombinant Human Insulin Sales and Growth Rate (2014-2019)
7 Asia-Pacific Recombinant Human Insulin by Country
7.1 Asia-Pacific Recombinant Human Insulin Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Recombinant Human Insulin Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Recombinant Human Insulin Revenue and Market Share by Country (2014-2019)
7.2 China Recombinant Human Insulin Sales and Growth Rate (2014-2019)
7.3 Japan Recombinant Human Insulin Sales and Growth Rate (2014-2019)
7.4 Korea Recombinant Human Insulin Sales and Growth Rate (2014-2019)
7.5 India Recombinant Human Insulin Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Recombinant Human Insulin Sales and Growth Rate (2014-2019)
8 South America Recombinant Human Insulin by Country
8.1 South America Recombinant Human Insulin Sales, Revenue and Market Share by Country
8.1.1 South America Recombinant Human Insulin Sales and Market Share by Country (2014-2019)
8.1.2 South America Recombinant Human Insulin Revenue and Market Share by Country (2014-2019)
8.2 Brazil Recombinant Human Insulin Sales and Growth Rate (2014-2019)
8.3 Argentina Recombinant Human Insulin Sales and Growth Rate (2014-2019)
8.4 Colombia Recombinant Human Insulin Sales and Growth Rate (2014-2019)
9 Middle East and Africa Recombinant Human Insulin by Countries
9.1 Middle East and Africa Recombinant Human Insulin Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Recombinant Human Insulin Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Recombinant Human Insulin Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Recombinant Human Insulin Sales and Growth Rate (2014-2019)
9.3 Turkey Recombinant Human Insulin Sales and Growth Rate (2014-2019)
9.4 Egypt Recombinant Human Insulin Sales and Growth Rate (2014-2019)
9.5 Nigeria Recombinant Human Insulin Sales and Growth Rate (2014-2019)
9.6 South Africa Recombinant Human Insulin Sales and Growth Rate (2014-2019)
10 Global Recombinant Human Insulin Market Segment by Type
10.1 Global Recombinant Human Insulin Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Recombinant Human Insulin Sales and Market Share by Type (2014-2019)
10.1.2 Global Recombinant Human Insulin Revenue and Market Share by Type (2014-2019)
11 Global Recombinant Human Insulin Market Segment by Application
11.1 Global Recombinant Human Insulin Sales Market Share by Application (2014-2019)
11.2 Type 1 Diabetes Mellitus Sales Growth (2014-2019)
11.3 Type 2 Diabetes Mellitus Sales Growth (2014-2019)
12 Recombinant Human Insulin Market Forecast (2019-2024)
12.1 Global Recombinant Human Insulin Sales, Revenue and Growth Rate (2019-2024)
12.2 Recombinant Human Insulin Market Forecast by Regions (2019-2024)
12.2.1 North America Recombinant Human Insulin Market Forecast (2019-2024)
12.2.2 Europe Recombinant Human Insulin Market Forecast (2019-2024)
12.2.3 Asia-Pacific Recombinant Human Insulin Market Forecast (2019-2024)
12.2.4 South America Recombinant Human Insulin Market Forecast (2019-2024)
12.2.5 Middle East and Africa Recombinant Human Insulin Market Forecast (2019-2024)
12.3 Recombinant Human Insulin Market Forecast by Type (2019-2024)
12.3.1 Global Recombinant Human Insulin Sales Forecast by Type (2019-2024)
12.3.2 Global Recombinant Human Insulin Market Share Forecast by Type (2019-2024)
12.4 Recombinant Human Insulin Market Forecast by Application (2019-2024)
12.4.1 Global Recombinant Human Insulin Sales Forecast by Application (2019-2024)
12.4.2 Global Recombinant Human Insulin Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Recombinant Human Insulin Picture
Table Product Specifications of Recombinant Human Insulin
Figure Global Sales Market Share of Recombinant Human Insulin by Types in 2018
Table Recombinant Human Insulin Types for Major Manufacturers
Figure Recombinant Human Insulin Sales Market Share by Applications in 2018
Figure Type 1 Diabetes Mellitus Picture
Figure Type 2 Diabetes Mellitus Picture
Figure United States Recombinant Human Insulin Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Recombinant Human Insulin Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Recombinant Human Insulin Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Recombinant Human Insulin Revenue (Value) and Growth Rate (2014-2024)
Figure France Recombinant Human Insulin Revenue (Value) and Growth Rate (2014-2024)
Figure UK Recombinant Human Insulin Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Recombinant Human Insulin Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Recombinant Human Insulin Revenue (Value) and Growth Rate (2014-2024)
Figure China Recombinant Human Insulin Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Recombinant Human Insulin Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Recombinant Human Insulin Revenue (Value) and Growth Rate (2014-2024)
Figure India Recombinant Human Insulin Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Recombinant Human Insulin Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Recombinant Human Insulin Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Recombinant Human Insulin Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Recombinant Human Insulin Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Recombinant Human Insulin Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Recombinant Human Insulin Revenue (Value) and Growth Rate (2014-2024)
Table Dongbro Pharmaceuticri Basic Information, Manufacturing Base and Competitors
Table Dongbro Pharmaceuticri Recombinant Human Insulin Type and Applications
Table Dongbro Pharmaceuticri Recombinant Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table Novo Nordisk Recombinant Human Insulin Type and Applications
Table Novo Nordisk Recombinant Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Wockhardt Basic Information, Manufacturing Base and Competitors
Table Wockhardt Recombinant Human Insulin Type and Applications
Table Wockhardt Recombinant Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Akron Biotech Basic Information, Manufacturing Base and Competitors
Table Akron Biotech Recombinant Human Insulin Type and Applications
Table Akron Biotech Recombinant Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Dance Biopharm Basic Information, Manufacturing Base and Competitors
Table Dance Biopharm Recombinant Human Insulin Type and Applications
Table Dance Biopharm Recombinant Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table United Laboratories Basic Information, Manufacturing Base and Competitors
Table United Laboratories Recombinant Human Insulin Type and Applications
Table United Laboratories Recombinant Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Gan & Lee Basic Information, Manufacturing Base and Competitors
Table Gan & Lee Recombinant Human Insulin Type and Applications
Table Gan & Lee Recombinant Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Recombinant Human Insulin Sales by Manufacturer (2017-2018)
Figure Global Recombinant Human Insulin Sales Market Share by Manufacturer in 2017
Figure Global Recombinant Human Insulin Sales Market Share by Manufacturer in 2018
Table Global Recombinant Human Insulin Revenue by Manufacturer (2017-2018)
Figure Global Recombinant Human Insulin Revenue Market Share by Manufacturer in 2017
Figure Global Recombinant Human Insulin Revenue Market Share by Manufacturer in 2018
Figure Top 3 Recombinant Human Insulin Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Recombinant Human Insulin Manufacturer (Revenue) Market Share in 2018
Figure Global Recombinant Human Insulin Sales and Growth Rate (2014-2019)
Figure Global Recombinant Human Insulin Revenue and Growth Rate (2014-2019)
Table Global Recombinant Human Insulin Sales by Regions (2014-2019)
Table Global Recombinant Human Insulin Sales Market Share by Regions (2014-2019)
Table Global Recombinant Human Insulin Revenue by Regions (2014-2019)
Figure Global Recombinant Human Insulin Revenue Market Share by Regions (2014-2019)
Figure Global Recombinant Human Insulin Revenue Market Share by Regions in 2018
Figure North America Recombinant Human Insulin Sales and Growth Rate (2014-2019)
Figure Europe Recombinant Human Insulin Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Recombinant Human Insulin Sales and Growth Rate (2014-2019)
Figure South America Recombinant Human Insulin Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Recombinant Human Insulin Sales and Growth Rate (2014-2019)
Figure North America Recombinant Human Insulin Revenue and Growth Rate (2014-2019)
Table North America Recombinant Human Insulin Sales by Countries (2014-2019)
Table North America Recombinant Human Insulin Sales Market Share by Countries (2014-2019)
Figure North America Recombinant Human Insulin Sales Market Share by Countries (2014-2019)
Figure North America Recombinant Human Insulin Sales Market Share by Countries in 2018
Table North America Recombinant Human Insulin Revenue by Countries (2014-2019)
Table North America Recombinant Human Insulin Revenue Market Share by Countries (2014-2019)
Figure North America Recombinant Human Insulin Revenue Market Share by Countries (2014-2019)
Figure North America Recombinant Human Insulin Revenue Market Share by Countries in 2018
Figure United States Recombinant Human Insulin Sales and Growth Rate (2014-2019)
Figure Canada Recombinant Human Insulin Sales and Growth Rate (2014-2019)
Figure Mexico Recombinant Human Insulin Sales and Growth Rate (2014-2019)
Figure Europe Recombinant Human Insulin Revenue and Growth Rate (2014-2019)
Table Europe Recombinant Human Insulin Sales by Countries (2014-2019)
Table Europe Recombinant Human Insulin Sales Market Share by Countries (2014-2019)
Table Europe Recombinant Human Insulin Revenue by Countries (2014-2019)
Figure Europe Recombinant Human Insulin Revenue Market Share by Countries (2014-2019)
Figure Europe Recombinant Human Insulin Revenue Market Share by Countries in 2018
Figure Germany Recombinant Human Insulin Sales and Growth Rate (2014-2019)
Figure UK Recombinant Human Insulin Sales and Growth Rate (2014-2019)
Figure France Recombinant Human Insulin Sales and Growth Rate (2014-2019)
Figure Russia Recombinant Human Insulin Sales and Growth Rate (2014-2019)
Figure Italy Recombinant Human Insulin Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Recombinant Human Insulin Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Recombinant Human Insulin Sales by Countries (2014-2019)
Table Asia-Pacific Recombinant Human Insulin Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Recombinant Human Insulin Sales Market Share by Countries 2018
Table Asia-Pacific Recombinant Human Insulin Revenue by Countries (2014-2019)
Figure Asia-Pacific Recombinant Human Insulin Revenue Market Share by Countries 2018
Figure China Recombinant Human Insulin Sales and Growth Rate (2014-2019)
Figure Japan Recombinant Human Insulin Sales and Growth Rate (2014-2019)
Figure Korea Recombinant Human Insulin Sales and Growth Rate (2014-2019)
Figure India Recombinant Human Insulin Sales and Growth Rate (2014-2019)
Figure Southeast Asia Recombinant Human Insulin Sales and Growth Rate (2014-2019)
Figure South America Recombinant Human Insulin Revenue and Growth Rate (2014-2019)
Table South America Recombinant Human Insulin Sales by Countries (2014-2019)
Table South America Recombinant Human Insulin Sales Market Share by Countries (2014-2019)
Figure South America Recombinant Human Insulin Sales Market Share by Countries in 2018
Table South America Recombinant Human Insulin Revenue by Countries (2014-2019)
Table South America Recombinant Human Insulin Revenue Market Share by Countries (2014-2019)
Figure South America Recombinant Human Insulin Revenue Market Share by Countries in 2018
Figure Brazil Recombinant Human Insulin Sales and Growth Rate (2014-2019)
Figure Argentina Recombinant Human Insulin Sales and Growth Rate (2014-2019)
Figure Colombia Recombinant Human Insulin Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Recombinant Human Insulin Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Recombinant Human Insulin Sales by Countries (2014-2019)
Table Middle East and Africa Recombinant Human Insulin Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Recombinant Human Insulin Sales Market Share by Countries in 2018
Table Middle East and Africa Recombinant Human Insulin Revenue by Countries (2014-2019)
Table Middle East and Africa Recombinant Human Insulin Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Recombinant Human Insulin Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Recombinant Human Insulin Revenue Market Share by Countries in 2018
Figure Saudi Arabia Recombinant Human Insulin Sales and Growth Rate (2014-2019)
Figure UAE Recombinant Human Insulin Sales and Growth Rate (2014-2019)
Figure Egypt Recombinant Human Insulin Sales and Growth Rate (2014-2019)
Figure Nigeria Recombinant Human Insulin Sales and Growth Rate (2014-2019)
Figure South Africa Recombinant Human Insulin Sales and Growth Rate (2014-2019)
Table Global Recombinant Human Insulin Sales by Type (2014-2019)
Table Global Recombinant Human Insulin Sales Share by Type (2014-2019)
Table Global Recombinant Human Insulin Revenue by Type (2014-2019)
Table Global Recombinant Human Insulin Revenue Share by Type (2014-2019)
Table Global Recombinant Human Insulin Sales by Application (2014-2019)
Table Global Recombinant Human Insulin Sales Share by Application (2014-2019)
Figure Global Type 1 Diabetes Mellitus Sales Growth (2014-2019)
Figure Global Type 2 Diabetes Mellitus Sales Growth (2014-2019)
Figure Global Recombinant Human Insulin Sales, Revenue and Growth Rate (2019-2024)
Table Global Recombinant Human Insulin Sales Forecast by Regions (2019-2024)
Table Global Recombinant Human Insulin Market Share Forecast by Regions (2019-2024)
Figure North America Sales Recombinant Human Insulin Market Forecast (2019-2024)
Figure Europe Sales Recombinant Human Insulin Market Forecast (2019-2024)
Figure Asia-Pacific Sales Recombinant Human Insulin Market Forecast (2019-2024)
Figure South America Sales Recombinant Human Insulin Market Forecast (2019-2024)
Figure Middle East and Africa Sales Recombinant Human Insulin Market Forecast (2019-2024)
Table Global Recombinant Human Insulin Sales Forecast by Type (2019-2024)
Table Global Recombinant Human Insulin Market Share Forecast by Type (2019-2024)
Table Global Recombinant Human Insulin Sales Forecast by Application (2019-2024)
Table Global Recombinant Human Insulin Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
スマート糖尿病管理の世界市場 2019年版：種類別（1型糖尿病、2型糖尿病）、用途別（病院、専門糖尿病クリニック、ホーム） Scope of the Report: The global Smart Diabetes Management market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China,…- 世界の自動制御インスリン注入システム市場予測（～2024年） The Automatic Insulin Delivery Systems, also known as artificial pancreas or hybrid closed loop automatically manages or withholds insulin in response to blood glucose measurements (via using continuous glucose monitors (CGMs) and smart algorithms). Scope of the Report: Asia-Pacific region is the la…
- 糖尿病治療薬市場：世界及び中国市場分析・予測（～2024年） Diabetes Drugs Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Diabetes Drugs industry with a focus on the Chinese market. The report provides key statistics on the market status of the Diabetes Drugs manufacturers and is a va…
- タイプ1糖尿病（T1D）市場：世界及び中国市場分析・予測（～2024年） Type 1 Diabetes (T1D) Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Type 1 Diabetes (T1D) industry with a focus on the Chinese market. The report provides key statistics on the market status of the Type 1 Diabetes (T1D) manu…
- 糖尿病ケア分析装置の世界市場 2019年版：種類別（ベンチトップ、ポータブル）、用途別（研究所、病院、その他） Scope of the Report: The worldwide market for Diabetes Care Analyzers is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Diabetes Care A…